from patients with clinically suspected CMV disease. Only patients who were HIV seronegative and who had not received any transplants were included. Medical records of the patients identified were reviewed with regard to demographics, clinical, laboratory data, and outcome.
CMV disease was defined as histological evidence of inflammation and the presence of CMV inclusion bodies confirmed by means of immunohistochemical staining, and the exclusion of any other pathogen, in a patient with clinical features compatible with CMV disease. Histological identification of CMV disease was made on the basis of the identification of CMV inclusion bodies in hematoxylin and eosin-stained and CMVspecific immunohistochemical stained sections of formalinfixed, paraffin-embedded samples [3] . In patient 1, CMV cultures of vitreous fluid were performed by use of the shell vial procedure [4] , and CMV PCR assay was performed with primer sets specific for a 368-bp amino acid signature sequence of the CMV early genome (Sharp Signal System; Digene Diagnostics) [5] . In the same patient, CMV pp65 antigen testing was performed by use of CMV Brite (Biotest Diagnostics).
Patients 1-3 were identified through infectious disease consultations. A review of the DMC Pathology Database from 1994 through 1998 indicated that 575 autopsies had been performed. CMV disease was identified in 11 (1.9%) of the autopsied patients. Of these 11 patients, 7 were HIV positive, 1 was a bone marrow transplant recipient, and 1 was a renal transplant recipient; the remaining 2 patients (patients 6 and 7) had none of the conventional risk factors. During the same time period, 284 biopsies were performed for clinically suspected CMV disease, and 60 patients (21%) had histological evidence of CMV disease. Of these 60 patients, 49 (82%) were HIV positive, 9 (15%) were transplant recipients, and only 2 (3%; patients 4 and 5) were neither. Thus, our results include 7 histologically proven cases of CMV disease (5 diagnosed antemortem and 2 diagnosed at autopsy). The clinical characteristics of the 7 patients identified are summarized intable 1.
Most patients were men (5 [71%] of 7) and the age range was 44-80 years. All patients had underlying comorbidities. The underlying illnesses most commonly identified were malignancy (4 [57%] of 7) and chronic renal failure (3 [43%] of 7). The most frequently affected organ was the colon (4 [57%] of 7). Clinical presentation was subacute, and symptoms were related to the specific organs affected. Constitutional symptoms, such as fever, were uncommon. Histopathological findings of CMV disease in tissue confirmed the diagnosis in all patients. Moreover, patient 1 had a positive result of PCR analysis of As our report indicates, CMV disease is rare in the patient population without HIV infection and without organ transplants. This is comparable to the experience reported in the literature. Autopsy studies of patients with cancer noted 3.3 cases of CMV disease per 1000 autopsies performed [6] and 2.2 cases of CMV pneumonia per 1000 autopsies performed [7] . A review of CMV disease of the gastrointestinal tract [8] in the patient population without HIV infection and without organ transplants identified only 38 cases in 1976-1992. As in our series, all of these reported cases occurred in patients with cancer or some other serious comorbidity.
CMV disease rarely occurs in people with no clinically apparent underlying illness [2, 9] . A retrospective review of all gastrointestinal biopsies performed in 1978-1992 identified CMV disease in 15 apparently immunocompetent patients [9] . More recently, Eddleston [2] described 1 case and identified an additional 33 that were described in the literature during a period of 29 years. However, underlying immunosuppressive conditions were not entirely excluded in these series [9] , and only 10 of 34 cases reported [2] were proven histologically. Therefore, the actual prevalence of well-documented CMV disease in immunocompetent hosts remains unclear. Since then, only a few additional case reports of histologically proven CMV colitis and retinitis in patients not usually at risk for CMV have been published [10] [11] [12] [13] [14] [15] .
A direct comparison of the patients in our study and those described in other case series is difficult because of the lack of documentation regarding histologically proven CMV disease. Moreover, clinical features, treatment, and outcomes were not provided in many of the earlier reports. However, certain similarities and contrasts can be distinguished. Most cases of CMV disease occurred in men [2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . CMV disease was diagnosed in older patients (median age, 72 years) in our series and in most other reports [6] [7] [8] [9] . Malignancy was the most common comorbidity identified in the patients in our study and among other patients reported [6] [7] [8] . Although the exact mechanism or mechanisms that predispose people to CMV disease is not clearly known, most of the comorbid conditions identified can affect cell-mediated immunity [16] . Clinical presentation of CMV disease reported elsewhere [8, [10] [11] [12] [13] [14] [15] was similar to that noted in the patients in our study, with symptoms generally subacute in nature and related to the organs affected; constitutional symptoms, including fever, were uncommon. The colon was the most affected organ in the patients in our study and in those described earlier [2, 6, [8] [9] [10] [11] . Disseminated CMV disease at the time of diagnosis was uncommon in patients with gastrointestinal CMV disease [8] [9] [10] [11] , a finding also noted in the patients in our study. This is in contrast to multiorgan involvement, which was reported in ∼50% of immunocompetent patients [2] and in autopsies of patients with cancer [6, 7] . Multiorgan involvement was associated with CMV pneumonia in almost all cases [2, [6] [7] and was noted in 1 (patient 6) of 2 patients in our study.
Histological evidence is generally required to establish the definitive diagnosis of CMV disease, with the exception of CMV retinitis. CMV cultures may support the diagnosis, but cultures were not performed for most patients, suggesting that the diagnosis of CMV disease often was not suspected before the histopathological report. Serological assays generally are not useful in the diagnosis of reactivation of CMV disease [1] . Newer tests, such as PCR and CMV antigen detection, appear to correlate with invasive CMV disease in high-risk, HIV-seropositive patients and transplant recipients [1] . Patient 1 had CMV detected in the vitreous humor by means of PCR, and also had concurrent CMV antigenemia. Therefore, these new noninvasive tests may have a potential but as-yet-undefined role in screening for CMV disease in appropriate low-risk patients.
Four of 5 patients in our series were promptly treated with ganciclovir, and all appeared to have a good clinical response, with resolution of symptoms and a favorable outcome. Similarly, 9 (75%) of 12 immunocompetent patients with CMV disease who received some antiviral therapy survived, in contrast to 10 (45%) of 22 who received no therapy [2] .
This case series had the intrinsic limitations of a retrospective study and included relatively few patients. However, the observations noted are useful, because the rare occurrence of invasive CMV disease in HIV-seronegative patients and in patients who did not receive transplants would likely preclude any large prospective study. In conclusion, CMV disease is rare but should be considered in patients with cancer or other serious illnesses who present with colitis or a compatible clinical syndrome, because early diagnosis and appropriate therapy with ganciclovir may improve outcome.
